The Impact of Rotavirus Vaccination on Discharges for Pediatric Gastroenteritis in Italy: An Eleven Year (2009-2019) Nationwide Analysis
- PMID: 37376427
- PMCID: PMC10300783
- DOI: 10.3390/vaccines11061037
The Impact of Rotavirus Vaccination on Discharges for Pediatric Gastroenteritis in Italy: An Eleven Year (2009-2019) Nationwide Analysis
Abstract
In Italy, despite the documented positive effects of rotavirus (RV) vaccination on reducing the burden of RV disease, an updated national assessment of its impact on clinical outcomes is still lacking. This study aims to analyze the implementation of RV vaccination in Italy, evaluating its impact on discharges for acute pediatric gastroenteritis (AGE). A retrospective analysis, including hospital discharge records and data on vaccination coverage for children aged 0-71 months from 2009 to 2019, was conducted. We examined trends in hospital discharge standardized incidence before and after vaccine introduction using a negative binomial mixture model with fixed effects to evaluate the impact of universal vaccination. The percentage of vaccination coverage increased over the years, from <5% between 2009 and 2013 to 26% in 2017, reaching 70% in 2019. The standardized incidence of discharges decreased over the period from 16.6/100,000 inhabitants in 2009-2013 to 9.9/100,000 inhabitants in 2018-2019. In this phase, about 15% of the estimated hospital discharges were avoided compared with those estimated in the first phase. The implementation of RV vaccination reduced AGE incidence discharges in children aged 0-71 months. Further efforts are needed to continue monitoring the vaccination effect over time and to increase vaccination coverage.
Keywords: discharges; pediatric gastroenteritis; rotavirus; rotavirus vaccine; vaccination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905. Ann Ig. 2013. PMID: 23435779 Italian.
-
Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey.Hum Vaccin Immunother. 2021 Feb 1;17(2):510-516. doi: 10.1080/21645515.2020.1776043. Epub 2020 Jul 23. Hum Vaccin Immunother. 2021. PMID: 32702249 Free PMC article.
-
Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily.Acta Biomed. 2018 Oct 8;89(3):437-442. doi: 10.23750/abm.v89i3.7578. Acta Biomed. 2018. PMID: 30333453 Free PMC article.
-
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.Expert Rev Vaccines. 2021 Dec;20(12):1499-1514. doi: 10.1080/14760584.2020.1853532. Epub 2021 Apr 20. Expert Rev Vaccines. 2021. PMID: 33275065 Review.
-
Rotavirus vaccination in Japan: Efficacy and safety of vaccines, changes in genotype, and surveillance efforts.J Infect Chemother. 2021 Jul;27(7):940-948. doi: 10.1016/j.jiac.2021.04.002. Epub 2021 Apr 15. J Infect Chemother. 2021. PMID: 33867267 Review.
Cited by
-
Rates and determinants of Rotavirus vaccine uptake among children in Italy: a cross-sectional study within the 2022 OBVIOUS* project.BMC Public Health. 2024 Mar 12;24(1):770. doi: 10.1186/s12889-024-18154-0. BMC Public Health. 2024. PMID: 38475736 Free PMC article.
References
-
- Tate J.E., Burton A.H., Boschi-Pinto C., Parashar U.D., Agocs M., Serhan F., De Oliveira L., Mwenda J.M., Mihigo R., Ranjan Wijesinghe P., et al. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000–2013. Clin. Infect. Dis. 2016;62:S96–S105. doi: 10.1093/cid/civ1013. - DOI - PubMed
-
- Troeger C., Khalil I.A., Rao P.C., Cao S., Blacker B.F., Ahmed T., Armah G., Bines J.E., Brewer T.G., Colombara D.V., et al. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea among Children Younger Than 5 Years. JAMA Pediatr. 2018;172:958–965. doi: 10.1001/jamapediatrics.2018.1960. - DOI - PMC - PubMed
-
- World Health Organization (WHO) Rotavirus. [(accessed on 11 December 2022)]; Available online: https://www.who.int/teams/health-product-policy-and-standards/standards-....
-
- Verberk J.D.M., van Dongen J.A.P., van de Kassteele J., Andrews N.J., van Gaalen R.D., Hahné S.J.M., Vennema H., Ramsay M., Braeckman T., Ladhani S., et al. Impact analysis of rotavirus vaccination in various geographic regions in Western Europe. Vaccine. 2021;39:6671–6681. doi: 10.1016/j.vaccine.2021.09.059. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources